JP5938295B2 - タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法 - Google Patents

タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法 Download PDF

Info

Publication number
JP5938295B2
JP5938295B2 JP2012179197A JP2012179197A JP5938295B2 JP 5938295 B2 JP5938295 B2 JP 5938295B2 JP 2012179197 A JP2012179197 A JP 2012179197A JP 2012179197 A JP2012179197 A JP 2012179197A JP 5938295 B2 JP5938295 B2 JP 5938295B2
Authority
JP
Japan
Prior art keywords
protein
activated carbon
flow
eluate
column
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012179197A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013044748A (ja
Inventor
ナーニン・ビアン
クリストフアー・ギレスピー
マシユウ・テイー・ストーン
ミハイル・コズロフ
ジエ・チエン
マーテイン・シワク
Original Assignee
イー・エム・デイー・ミリポア・コーポレイシヨン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イー・エム・デイー・ミリポア・コーポレイシヨン filed Critical イー・エム・デイー・ミリポア・コーポレイシヨン
Publication of JP2013044748A publication Critical patent/JP2013044748A/ja
Application granted granted Critical
Publication of JP5938295B2 publication Critical patent/JP5938295B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/12—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
    • B01D15/125—Pre-filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J43/00—Amphoteric ion-exchange, i.e. using ion-exchangers having cationic and anionic groups; Use of material as amphoteric ion-exchangers; Treatment of material for improving their amphoteric ion-exchange properties
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/02—Column or bed processes
    • B01J47/04—Mixed-bed processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2012179197A 2011-08-19 2012-08-13 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法 Active JP5938295B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161575349P 2011-08-19 2011-08-19
US61/575,349 2011-08-19
US201261666240P 2012-06-29 2012-06-29
US61/666,240 2012-06-29

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2014246058A Division JP6254072B2 (ja) 2011-08-19 2014-12-04 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法
JP2016022509A Division JP6339120B2 (ja) 2011-08-19 2016-02-09 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法

Publications (2)

Publication Number Publication Date
JP2013044748A JP2013044748A (ja) 2013-03-04
JP5938295B2 true JP5938295B2 (ja) 2016-06-22

Family

ID=47076067

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012179197A Active JP5938295B2 (ja) 2011-08-19 2012-08-13 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法
JP2014246058A Active JP6254072B2 (ja) 2011-08-19 2014-12-04 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法
JP2016022509A Active JP6339120B2 (ja) 2011-08-19 2016-02-09 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法
JP2018017028A Active JP6743074B2 (ja) 2011-08-19 2018-02-02 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2014246058A Active JP6254072B2 (ja) 2011-08-19 2014-12-04 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法
JP2016022509A Active JP6339120B2 (ja) 2011-08-19 2016-02-09 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法
JP2018017028A Active JP6743074B2 (ja) 2011-08-19 2018-02-02 タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法

Country Status (8)

Country Link
US (3) US9096648B2 (https=)
EP (2) EP2574618B1 (https=)
JP (4) JP5938295B2 (https=)
KR (1) KR101484659B1 (https=)
CN (3) CN102977182B (https=)
ES (2) ES2677650T3 (https=)
TW (1) TWI574975B (https=)
WO (1) WO2013028330A2 (https=)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11395980B2 (en) 2010-01-25 2022-07-26 Spf Technologies Llc Chromatographic cassette
US10507409B2 (en) * 2016-03-12 2019-12-17 Spf Technologies, Llc Hyper-productive chromatography system and process
US9096648B2 (en) * 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
WO2014004103A1 (en) 2012-06-29 2014-01-03 Emd Millipore Corporation Methods for inactivating viruses during a protein purification process
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9650411B2 (en) * 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
JP6067889B2 (ja) * 2013-02-26 2017-01-25 イー・エム・デイー・ミリポア・コーポレイシヨン 溶液条件を調整することによる活性化炭素を使用したタンパク質混合物からの１種のタンパク質の選択的除去
DK2968494T3 (en) * 2013-03-13 2019-03-04 Seattle Genetics Inc ACTIVATED CARBON FILTERING FOR CLEANING BENZODIAZEPINE ADCs
EP3301115B1 (en) * 2013-05-06 2021-11-10 Sanofi Continuous multistep process for purifying antibodies
WO2015005960A1 (en) * 2013-07-12 2015-01-15 Emd Millipore Corporation Removal of fragments from a sample containing a target protein using activated carbon
US9910041B2 (en) 2013-07-12 2018-03-06 Emd Millipore Corporation Method of determining virus removal from a sample containing a target protein using activated carbon
CN120904322A (zh) * 2013-09-13 2025-11-07 豪夫迈·罗氏有限公司 包含纯化的重组多肽的方法和组合物
CN103497248B (zh) * 2013-09-22 2016-08-10 中国抗体制药有限公司 一种从细胞培养上清中分离纯化抗体的方法
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
WO2015131978A1 (en) * 2014-03-04 2015-09-11 Merck Patent Gmbh Robust antibody purification
JP6702587B2 (ja) * 2014-03-14 2020-06-03 ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ 生物粒子の精製用分離マトリックス
CA2966764C (en) * 2014-11-06 2022-10-18 Merck Patent Gmbh Activated carbon for the removal of leachables and/or extractables
ES3006358T3 (en) * 2015-03-13 2025-03-18 Novimmune Sa Methods of purifying bispecific antibodies
DK3334747T5 (da) * 2015-08-13 2024-10-07 Amgen Inc Ladet dybdefiltrering af antigenbindende proteiner
KR20180048731A (ko) * 2015-08-20 2018-05-10 제넨테크, 인크. 재조합 폴리펩티드를 제조하기 위한 fkpa의 정제 및 그의 용도
US12409440B1 (en) 2016-01-26 2025-09-09 Spf Technologies Llc Separation module
EP3430072B1 (en) * 2016-03-17 2020-07-01 Merck Patent GmbH Method for purifying poloxamers
EP3436473A4 (en) * 2016-03-29 2019-10-23 Navya Biologicals Pvt. Ltd. METHOD FOR PURIFYING FC FUSION PROTEINS
MX2018011435A (es) 2016-04-01 2019-01-10 Ucb Biopharma Sprl Metodo para purificacion de proteinas.
WO2018092691A1 (ja) * 2016-11-18 2018-05-24 Jnc株式会社 抗体の精製方法
WO2018183971A1 (en) * 2017-04-01 2018-10-04 Massachusetts Institute Of Technology Systems and methods for manufacturing biologically-produced products
US20200247911A1 (en) * 2017-05-17 2020-08-06 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. Purification of Bacterial Polysaccharides
CN107236038B (zh) * 2017-06-20 2020-11-27 华兰生物工程股份有限公司 微晶纤维素提高蛋白质澄清度的方法及其产品和应用
MA49962A (fr) 2017-08-22 2020-07-01 Biogen Ma Inc Procédés de purification d'anticorps présentant des agrégats réduits à poids moléculaire élevé
JP2020532414A (ja) 2017-08-31 2020-11-12 マサチューセッツ インスティテュート オブ テクノロジー 中空糸膜濾過システムおよび生物学的に生成される生成物を製造するための方法
US11071927B2 (en) * 2017-11-15 2021-07-27 Arup Laboratories, Inc. Separating and quantifying unbound target analytes from biological samples
CN109929038B (zh) * 2017-12-15 2020-10-09 山东博安生物技术有限公司 Vegf捕获剂融合蛋白的纯化方法
US12343702B2 (en) 2018-03-08 2025-07-01 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resin
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US20210122783A1 (en) * 2018-06-19 2021-04-29 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
EP4509831A3 (en) * 2018-07-27 2025-03-19 Waters Technologies Corporation Liquid chromatography/mass spectrometry methods for the analysis of polar molecules
US12172108B2 (en) 2018-08-16 2024-12-24 Emd Millipore Corporation Closed bioprocessing device
CN111215027A (zh) * 2018-11-26 2020-06-02 中国科学院大连化学物理研究所 一种水热碳微球色谱介质的修饰方法
US20220041650A1 (en) * 2018-12-03 2022-02-10 Duke University Purification method for recombinant proteins and nanoparticles
KR102120675B1 (ko) * 2018-12-05 2020-06-09 유바이오주식회사 바이러스 클리어런스 공정을 포함하는 봉독의 정제방법 및 이를 이용한 염증성 질환 예방 또는 치료용 조성물
US11918957B2 (en) 2018-12-12 2024-03-05 Donaldson Company, Inc. Affinity membrane and method of preparation
WO2020153390A1 (ja) 2019-01-23 2020-07-30 第一三共株式会社 活性炭材料を使用する工程を含む抗体精製方法
US12371482B2 (en) * 2019-04-02 2025-07-29 Council Of Scientific & Industrial Research Cloning and expression of in vivo refolded antibody fragment
JP2022531317A (ja) 2019-05-03 2022-07-06 ジェネンテック， インコーポレイテッド 精製プラットフォームから得られた組成物中の酵素加水分解活性速度を低下させる方法
WO2021046284A1 (en) 2019-09-05 2021-03-11 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resins
SG11202110968VA (en) 2019-12-06 2021-10-28 Regeneron Pharma Anti-vegf protein compositions and methods for producing the same
US20210178334A1 (en) * 2019-12-16 2021-06-17 Dionex Corporation Electrolytic eluent generators with stabilized operating voltages
EP4090666A1 (en) 2020-01-15 2022-11-23 F. Hoffmann-La Roche AG Methods to decrease impurities from recombinant protein manufacturing processes
US20230227496A1 (en) * 2020-04-13 2023-07-20 3M Innovative Properties Company Flow-through processes and devices for purifying a target molecule
AU2021268026A1 (en) 2020-05-08 2023-01-19 Regeneron Pharmaceuticals, Inc. VEGF traps and mini-traps and methods for treating ocular disorders and cancer
CA3198684A1 (en) * 2020-10-30 2022-05-05 Genentech, Inc. Purification platforms for obtaining pharmaceutical compositions having a reduced hydrolytic enzyme activity rate
CA3198265A1 (en) * 2020-11-20 2022-05-27 Nicolas-Julian HILBOLD Buffers and methods for purifying proteins
US11884702B2 (en) 2020-12-28 2024-01-30 Plasma Technologies, Llc Systems and methods for process scale isolation of immunoglobulin G
CN112870979B (zh) * 2020-12-31 2022-12-23 内蒙古金达威药业有限公司 一种β-烟酰胺单核苷酸的分离纯化方法
CN115326937B (zh) * 2021-05-11 2024-06-18 山东省食品药品检验研究院 一种基因毒杂质捕捉用固相探针及其使用方法与应用
EP4423109A4 (en) 2021-10-27 2025-12-24 Plasma Tech Llc COMPOSITIONS AND METHODS FOR ISOLATING PROTEINS
CN116375808A (zh) * 2022-12-30 2023-07-04 中国科学院武汉病毒研究所 一种huh固相结合蛋白及其介导的蛋白或核酸的固相结合方法
CN116120392B (zh) * 2023-04-18 2023-08-01 上海健士拜生物科技有限公司 聚体蛋白的纯化方法
CN118126110B (zh) * 2024-05-10 2024-08-06 江苏赛孚士生物技术有限公司 一种纯化单克隆抗体的方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31093A (en) 1861-01-08 Mode of constructing iron pavements
USRE31093E (en) 1978-05-10 1982-11-30 Westvaco Corporation Process for making activated carbon with control of metal ion concentration in phosphoric acid
JPS5918731A (ja) 1982-07-21 1984-01-31 Toray Ind Inc イオン交換繊維
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE3927112C1 (https=) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
GB8923662D0 (en) 1989-10-20 1989-12-06 Norit Uk Ltd A method of producing granular activated carbon
JPH0778025B2 (ja) * 1990-03-20 1995-08-23 日本赤十字社 免疫グロブリンｇの製造方法
US5204310A (en) 1992-02-21 1993-04-20 Westvaco Corporation High activity, high density activated carbon
US5612558A (en) 1995-11-15 1997-03-18 Micron Technology, Inc. Hemispherical grained silicon on refractory metal nitride
US20020056686A1 (en) * 1996-06-14 2002-05-16 Agathagelos Kyrlidis Chromatography and other adsorptions using modified carbon adsorbents
DE29801192U1 (de) 1998-01-26 1998-08-20 Hans Bernstein Spezialfabrik für Schaltkontakte GmbH & Co, 32457 Porta Westfalica Radiusbetätiger für Sicherheitsschalter
DE19935160A1 (de) 1999-07-27 2001-02-15 Grove Us Llc Shady Grove Vorrichtung zur Erhöhung der Lenkfähigkeit getriebener Achsen
US6569910B1 (en) 1999-10-27 2003-05-27 Basf Aktiengesellschaft Ion exchange resins and methods of making the same
WO2003072640A2 (en) 2002-02-25 2003-09-04 Cabot Coproration Compositions comprising continuous networks and monoliths
US7332304B2 (en) 2002-07-01 2008-02-19 Arkion Life Sciences Llc Process and materials for production of glucosamine and N-acetylglucosamine
CA2516518A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
US20080058507A1 (en) 2004-02-11 2008-03-06 Hui Liu Method For The Removal Of Aggregate Proteins From Recombinant Samples Using Ion Exchange Chromatography
SE0402558D0 (sv) * 2004-10-21 2004-10-21 Amersham Biosciences Ab A process for the purification of antibodies
US7390403B2 (en) 2004-03-19 2008-06-24 Millipore Corporation Prefilter system for biological systems
CA2594276A1 (en) * 2004-12-30 2006-07-13 Schering-Plough Ltd. Neutralizing epitope-based growth enhancing vaccine
WO2007063129A2 (en) 2005-12-02 2007-06-07 Novozymes A/S Insolation of peptides , polypeptides and proteins
JP5209490B2 (ja) 2005-12-08 2013-06-12 ウオーターズ・テクノロジーズ・コーポレイシヨン 溶液からペプチド及びタンパク質試料を調製するための装置及び方法
WO2008025747A1 (en) 2006-08-28 2008-03-06 Ares Trading S.A. Process for the purification of fc-fusion proteins
CA2570956C (en) * 2006-12-12 2014-04-01 Norgen Biotek Corporation Method of using silicon carbide for removal of adventitious agents
CN101679509A (zh) 2007-06-01 2010-03-24 弗·哈夫曼-拉罗切有限公司 免疫球蛋白纯化
JP2010279461A (ja) 2009-06-03 2010-12-16 Daicen Membrane Systems Ltd 人工透析液又は人工透析用水の清浄化方法
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
EP3309168A1 (en) 2009-08-06 2018-04-18 F. Hoffmann-La Roche AG Method to improve virus removal in protein purification
EP2462157B1 (en) 2009-08-07 2020-06-17 EMD Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
US20130116413A1 (en) * 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
EP2744518A2 (en) * 2011-08-19 2014-06-25 EMD Millipore Corporation Use of small molecules in methods for purification of biomolecules
US9096648B2 (en) 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
WO2015005960A1 (en) * 2013-07-12 2015-01-15 Emd Millipore Corporation Removal of fragments from a sample containing a target protein using activated carbon

Also Published As

Publication number Publication date
KR20130020950A (ko) 2013-03-04
JP2013044748A (ja) 2013-03-04
JP6339120B2 (ja) 2018-06-06
CN111423488B (zh) 2024-08-16
TWI574975B (zh) 2017-03-21
EP2942353A1 (en) 2015-11-11
JP2015071629A (ja) 2015-04-16
WO2013028330A2 (en) 2013-02-28
CN111423488A (zh) 2020-07-17
US20130197200A1 (en) 2013-08-01
CN105669829A (zh) 2016-06-15
ES2677650T3 (es) 2018-08-06
EP2942353B1 (en) 2018-05-09
US20190218250A1 (en) 2019-07-18
ES2539232T3 (es) 2015-06-29
US11634457B2 (en) 2023-04-25
JP6743074B2 (ja) 2020-08-19
CN105669829B (zh) 2020-04-21
KR101484659B1 (ko) 2015-01-21
US9096648B2 (en) 2015-08-04
TW201313735A (zh) 2013-04-01
JP6254072B2 (ja) 2017-12-27
CN102977182A (zh) 2013-03-20
CN102977182B (zh) 2016-03-02
WO2013028330A3 (en) 2013-08-22
JP2016085231A (ja) 2016-05-19
EP2574618A1 (en) 2013-04-03
US20160016992A1 (en) 2016-01-21
US10287314B2 (en) 2019-05-14
EP2574618B1 (en) 2015-03-18
JP2018091858A (ja) 2018-06-14

Similar Documents

Publication Publication Date Title
JP6339120B2 (ja) タンパク質精製中に試料中の１または複数の不純物のレベルを低下させる方法
KR101415660B1 (ko) 샘플 중의 1 이상의 불순물로부터 표적 단백질을 정제하는 방법
KR101921552B1 (ko) 사전 세정 단계를 이용하는 면역글로불린 정제
JP2017110017A (ja) 生体分子の精製
KR20210149089A (ko) 사전 포획 응집을 이용하는 것에 의한 면역글로불린의 친화성 크로마토그래피 개선
KR101847004B1 (ko) 표적 단백질을 함유하는 샘플로부터 단편들의 활성탄을 이용한 제거
RU2794431C1 (ru) Улучшение аффинной хроматографии иммуноглобулинов путем применения флокуляции до захвата

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130910

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130911

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131206

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131211

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141204

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150115

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160317

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160516

R150 Certificate of patent or registration of utility model

Ref document number: 5938295

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250